Measuring outcomes

IN ACTION: Identify aNd ACT In Obesity Now advanced course

Advanced course | Hours: 4.5 | EA: 1.5 | MO: 2 | RP: 1

This highly practical advanced course will help you to understand the science of obesity and overcome barriers to effective obesity management in your practice and is presented by A/Prof Gary Kilov AM and Dr Kevin Lee.

Read more about IN ACTION: Identify aNd ACT In Obesity Now advanced course

Clinical audit: Herpes zoster prevention in older people

Clinical audit | Hours: 6 | EA: 1 | MO: 4 | RP: 1 | GPs only

This clinical audit will guide GPs through the process of identifying patients for whom herpes zoster (HZ) vaccination is recommended, and outlines the evidence and current Australian recommendations for selecting the most appropriate type of HZ vaccine for each patient.

Read more about Clinical audit: Herpes zoster prevention in older people

Food cravings in people who are overweight or living with obesity

Hours: 2 | EA: 1 | MO: 1 | RP: 0

Food cravings are an intense desire to eat highly palatable and energy-dense foods and are among the main influencers of eating behaviour. In this module you will learn best practice steps to manage patients, then undertake a practical exercise to identify a patient who is overweight or living with obesity from your practice in order to reflect on latest evidence.

Read more about Food cravings in people who are overweight or living with obesity

Metabolic-associated fatty liver disease clinical audit

Clinical audit | Hours: 6 | EA: 1 | MO: 4 | RP: 1 | GPs only

In this clinical audit, you will conduct an assessment of patients who are at risk of metabolic associated fatty liver disease (MAFLD), calculate their risk of liver fibrosis using validated tools and decide on further management.

Read more about Metabolic-associated fatty liver disease clinical audit

Practical use of long-acting injectable buprenorphine for the treatment of opioid dependence

Hours: 2 | EA: 1 | MO: 1 | RP: 0

Module 2 of 2: This two-part activity provides education on the various long-acting buprenorphine (LAIB) formulations available in Australia, followed by a practical exercise where the learner goes through the steps of assessing whether a patient is suitable for LAIB treatment, and discusses with them how treatment may help them achieve their goals.